Effects of the REMEEX systemⓇ in Female Patients with Intrinsic Sphincteric Deficiency and Recurrent Urinary Incontinence: Ten-Year Outcomes

Jung H C1, Ko Y H1, Choi J Y1, Moon K H1

Research Type

Clinical

Abstract Category

Female Stress Urinary Incontinence (SUI)

Abstract 368
Open Discussion ePosters
Scientific Open Discussion Session 21
Thursday 30th August 2018
13:15 - 13:20 (ePoster Station 6)
Exhibition Hall
Clinical Trial Incontinence Retrospective Study Stress Urinary Incontinence Female
1. Yeungnam University Medical Center
Presenter
Links

Abstract

Hypothesis / aims of study
To evaluate the long-term outcomes of the REMEEX systemⓇ (EXternal MEchanical REgulation, Neomedic International, Terrassa (Barcelona), Spain) for treatment of recurrent urinary incontinence (UI) and intrinsic sphincteric deficiency (ISD).
Study design, materials and methods
A total of 24 (mean age, 67.2±7.4 years) patients who underwent REMEEX systemⓇ for UI and ISD were included and followed up for at 10 years postoperatively. Patients were categorized into failed UI (Group A, 9 patients) and ISD (Group B, 15 patients). The success rate of patients after surgery was assessed by cure and satisfaction rate. Clinical, urodynamic, peri and post-operative data with respect to success rates were analyzed.
Results
The mean follow-up period was 120.4 months (range 117-130). At 10 years after surgery, the overall cure rates with REMEEX systemⓇ (Group A/Group B) were 82.4%/71.1%, with a satisfaction rate of 78.1%/65.4% in group A and B, respectively. Three patients (12.5%) experienced wound infections. Of these, two patients were treated using intravenous antibiotics but the other had their varitensor removed.
Interpretation of results
The REMEEX systemⓇ may be an effective procedure regardless of previous incontinence surgical interventions and ISD.
Concluding message
The REMEEX systemⓇ may be an effective procedure regardless of previous incontinence surgical interventions and ISD. The correct sling tension is easily achieved during the early postoperative period, and when necessary, is able to convert late failures into cures. The problems of recurrent UI during the follow-up period were also resolved successfully in every case.
Disclosures
Funding None Clinical Trial Yes Public Registry No RCT No Subjects Human
20/11/2024 14:45:57